Literature DB >> 14517521

Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children.

Yasunori Okada1, Makoto Shinohara, Tomio Kobayashi, Yoshinari Inoue, Takeshi Tomomasa, Tohru Kobayashi, Akihiro Morikawa.   

Abstract

OBJECTIVE: The aim of this multicenter prospective and randomized study was to determine the effect of adding corticosteroids to intravenous gamma globulin (i.v.GG) therapy on serum cytokine levels, as well as to see its effect on the clinical course in children in the acute phase of Kawasaki disease (KD). STUDY
DESIGN: Patients with KD (n=32) were randomized to receive either i.v.GG alone (G group) or i.v.GG plus corticosteroids (G+S group). The clinical course and cytokine responses between groups were compared.
RESULTS: The pretreatment serum levels of interleukin (IL)-2, IL-6, IL-8, and IL-10 were significantly higher in patients with KD than in healthy controls. Although i.v.GG alone failed to reduce cytokine concentrations within 24 hours of i.v.GG administration, corticosteroids plus i.v.GG reduced IL-2, IL-6, IL-8, and IL-10 levels. The levels of IL-2, IL-6, IL-8, and IL-10 within 24 hours after initiating i.v.GG therapy were significantly lower in the G+S group than in the G group. The duration of fever was shorter, and the C-reactive protein concentration decreased more quickly in the G+S group than in the G group.
CONCLUSIONS: These findings suggest that corticosteroids rapidly ameliorate symptoms by reducing cytokine levels in children with KD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14517521     DOI: 10.1067/s0022-3476(03)00387-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  26 in total

1.  [Kawasaki disease in children and adolescents].

Authors:  U Neudorf
Journal:  Z Rheumatol       Date:  2011-12       Impact factor: 1.372

Review 2.  Use of corticosteroids during acute phase of Kawasaki disease.

Authors:  Jeong Jin Yu
Journal:  World J Clin Pediatr       Date:  2015-11-08

Review 3.  Recent Advances in Kawasaki Disease - Proceedings of the 3rd Kawasaki Disease Summit, Chandigarh, 2014.

Authors:  Surjit Singh; Dhrubajyoti Sharma; Sagar Bhattad; Saji Phillip
Journal:  Indian J Pediatr       Date:  2015-08-30       Impact factor: 1.967

4.  The inclusion of corticosteroids in treatment regimens for Kawasaki disease: effect on coronary aneurysms.

Authors:  Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

5.  Association of promoter genetic variants in interleukin-10 and Kawasaki disease with coronary artery aneurysms.

Authors:  Ying-Ju Lin; Yu-Ching Lan; Chih-Ho Lai; Ting-Hsu Lin; Shao-Mei Huang; Chiu-Chu Liao; Cheng-Wen Lin; Chien-Hui Hung; Ni Tien; Xiang Liu; Wen-Kuei Chien; Jin-Hua Chen; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

6.  Regulation of oxidative stress in patients with Kawasaki disease.

Authors:  Kaori Sekine; Hiroyuki Mochizuki; Yoshinari Inoue; Tohru Kobayashi; Eisuke Suganuma; Shinichi Matsuda; Hirokazu Arakawa
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

7.  Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease.

Authors:  Haruyuki Makata; Takashi Ichiyama; Ryutaro Uchi; Tsuyoshi Takekawa; Tomoyo Matsubara; Susumu Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-01       Impact factor: 3.000

8.  Steroid pulse therapy for Kawasaki disease unresponsive to additional immunoglobulin therapy.

Authors:  Masaru Miura; Takuya Tamame; Takashi Naganuma; Shino Chinen; Megumi Matsuoka; Hirotaka Ohki
Journal:  Paediatr Child Health       Date:  2011-10       Impact factor: 2.253

Review 9.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

10.  Primary treatment of kawasaki disease with corticosteroids.

Authors:  Swati Singhal; Devendra Mishra; Sumod Kurien; Monica Juneja
Journal:  J Clin Diagn Res       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.